Key points are not available for this paper at this time.
We read with interest the article by Schellhaas et al (B. Schellhaas et al. Ultraschall in Med 2016; 37: 627–634). While their study may contribute to the ongoing validation of CEUS as a non-invasive method for HCC diagnosis in at-risk patients, we take exception to their inappropriate and misleading adoption of the term "CEUS –LI-RADS".
Kono et al. (Wed,) studied this question.